- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DND PharmaTech Inc (347850)
DND PharmaTech Inc stock price live, this page displays KQ 347850 stock exchange data. View the 347850 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DND PharmaTech Inc real time stock price chart below.
What Is the DND PharmaTech Inc Stock Price Today?
The DND PharmaTech Inc stock price today is 107,500.
What Is the Stock Symbol for DND PharmaTech Inc?
The stock ticker symbol for DND PharmaTech Inc is 347850.
Is 347850 the Same as $347850?
$347850 is a common way to refer to the DND PharmaTech Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does DND PharmaTech Inc Trade On?
DND PharmaTech Inc is listed and trades on the KOSDAQ stock exchange.
Is DND PharmaTech Inc a Good Stock to Buy?
Determining whether DND PharmaTech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current DND PharmaTech Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 347850 quote. (ISIN: KR7347850000)
What Is the DND PharmaTech Inc Stock Price Today?
The DND PharmaTech Inc stock price today is 107,500.
What Is the Stock Symbol for DND PharmaTech Inc?
The stock ticker symbol for DND PharmaTech Inc is 347850.
Is 347850 the Same as $347850?
$347850 is a common way to refer to the DND PharmaTech Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does DND PharmaTech Inc Trade On?
DND PharmaTech Inc is listed and trades on the KOSDAQ stock exchange.
Is DND PharmaTech Inc a Good Stock to Buy?
Determining whether DND PharmaTech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current DND PharmaTech Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 347850 quote. (ISIN: KR7347850000)
107,500
-3,700(-3.33%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
101,600
113,100
52 wk Range
27,825
200,500
347850 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
101,600113,100
52 wk Range
27,825200,500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
347850 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Earnings
Latest Release
May 15, 2026
EPS / Forecast
-217.71 / --
Revenue / Forecast
128.78M / --
Compare 347850 to Peers and Sector
Metrics to compare | 347850 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship347850PeersSector | |
|---|---|---|---|---|
P/E Ratio | −210.0x | −19.4x | −0.4x | |
PEG Ratio | - | −0.52 | 0.00 | |
Price / Book | 65.4x | 2.9x | 2.6x | |
Price / LTM Sales | 1,616.7x | 29.1x | 3.0x | |
Upside (Analyst Target) | - | 58.2% | 58.1% | |
Fair Value Upside | Unlock | 20.4% | 8.2% | Unlock |
D&D Pharmatech Inc. engages in the research and development and manufacturing of pharmaceuticals in South Korea. It develops oral peptides, such as MET-002o, MET-224o, MET-097o, DD03, DD07, and DD14 programs for obesity indications in the development phase; injectable peptides, including DD01 for MASH indications; NLY12 and DD15 for obesity indications; and Pegsebrenatide (NLY01) for Parkinson’s and Alzheimer’s diseases. The company is also involved in the development of TLY012, an injectable protein for systemic sclerosis, liver fibrosis, and chronic pancreatitis indications; NLY02, an oral small molecule for PD and AD indications; and P4M01 for anti-microbial peptide indications. In addition, it develops PMI07, PMI05, and PMI06 for solid tumor imaging biomarker indications; and PMI04 for neuroinflammation indications. The company was founded in 2014 and is based in Seongnam-si, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the DND PharmaTech (347850) Stock Price Today?
The DND PharmaTech stock price today is 107,500 KRW.
What Stock Exchange Does DND PharmaTech Trade On?
DND PharmaTech is listed and trades on the KOSDAQ.
What Is the Stock Symbol for DND PharmaTech?
The stock symbol for DND PharmaTech is "347850."
What Is the DND PharmaTech Market Cap?
As of today, DND PharmaTech market cap is 4.87T KRW.
What Is DND PharmaTech's Earnings Per Share (TTM)?
The DND PharmaTech EPS (TTM) is -774.
From a Technical Analysis Perspective, Is 347850 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has DND PharmaTech Stock Split?
DND PharmaTech has split 1 times.
What is the current trading status of DND PharmaTech (347850)?
As of Jun 22, 2026, DND PharmaTech (347850) is trading at a price of 107,500 KRW, with a previous close of 111,200 KRW. The stock has fluctuated within a day range of 101,600 KRW to 113,100 KRW, while its 52-week range spans from 27,825 KRW to 200,500 KRW.
Industry Spotlight
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.